Can a common arthritis drug ease chikungunya joint pain? new trial seeks answers.
NCT ID NCT04483466
First seen Oct 31, 2025 · Last updated May 06, 2026 · Updated 21 times
Summary
This study tests whether methotrexate, a drug used for rheumatoid arthritis, can reduce joint swelling and pain in people with chronic arthritis caused by chikungunya virus. About 150 adults in Colombia will receive either methotrexate or a placebo for 6 months. The goal is to see if the drug improves disease activity scores and reduces inflammation in joint tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVESTIGATE THE EFFECT(S) OF METHOTREXATE TREATMENT ON ARTHRITIS DISEASE SEVERITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinica de la Costa
Barranquilla, Colombia
Conditions
Explore the condition pages connected to this study.